Clinical Trial Update: A Study To Evaluate PF-05175157 In Healthy Volunteers [Phase 1]

View source ↗

Summary

Pfizer conducted a Phase 1 study of PF-05175157 in healthy volunteers to assess safety and pharmacology for potential use in Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PF-05175157

Snippet

Sponsor: Pfizer | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED